LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 73.48 27.76 2478 6957 0.3562 0.7570
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 73.48 27.76 5911 6957 0.8496 0.9595
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 75.19 27.76 4639 7015 0.6613 0.8990
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 75.19 27.76 7178 7015 1.0232 1.0058
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 75.19 27.76 2198 7015 0.3133 0.7294
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 75.19 27.76 5996 7015 0.8547 0.9611
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 76.89 27.76 4948 7025 0.7043 0.9141
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 76.89 27.76 7351 7025 1.0464 1.0114
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 76.89 27.76 1925 7025 0.2740 0.7006
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 76.89 27.76 6106 7025 0.8692 0.9652
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 78.60 27.76 5059 7045 0.7180 0.9188
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 78.60 27.76 7517 7045 1.0669 1.0163
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 78.60 27.76 1883 7045 0.2673 0.6955
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 78.60 27.76 6218 7045 0.8825 0.9690
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 80.31 27.76 5028 6976 0.7207 0.9195
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 80.31 27.76 7690 6976 1.1023 1.0246
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 80.31 27.76 1745 6976 0.2501 0.6809
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 80.31 27.76 6307 6976 0.9041 0.9749
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 82.01 27.76 5116 7000 0.7308 0.9229
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 82.01 27.76 7883 7000 1.1261 1.0300
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 82.01 27.76 1660 7000 0.2371 0.6699
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 82.01 27.76 6449 7000 0.9212 0.9795
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 83.72 27.76 5080 7055 0.7200 0.9194
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 83.72 27.76 8044 7055 1.1401 1.0331
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 83.72 27.76 1615 7055 0.2289 0.6630
MN20160318_Q01
D12